Patent No. US11077404 (titled "Process Control Systems And Methods For Use With Filters And Filtration Processes") was filed by Amgen Inc on Jan 15, 2020.
’404 is related to the field of process control systems, specifically those used in filtration processes within biopharmaceutical manufacturing. The background involves preparing cell-derived products like monoclonal antibodies, which require multiple filtration steps for cell debris removal, purification via chromatography, and final concentration/desalting. Tangential flow filtration (TFF), especially single-pass TFF (SPTFF), offers advantages over dead-end filtration for continuous processing due to reduced membrane fouling.
The underlying idea behind ’404 is to actively control the concentration of a product stream using a single-pass tangential flow filtration (SPTFF) unit by manipulating the permeate flow rate. This is achieved by varying the flow reduction factor (FRF), which is the ratio of feed flow to retentate flow, to achieve a desired volume reduction factor (VRF). The key insight is that by adjusting the permeate pump speed based on the changing product concentration, a target VRF can be reached even with a variable feed concentration.
The claims of ’404 focus on a process control system and method that uses a microfiltration unit coupled with a single-pass tangential flow filter . A feed pump moves fluid from the microfiltration unit to the SPTFF, while a permeate pump controls the permeate flow. The core of the invention lies in a control system that adjusts the permeate pump to vary the flow reduction factor (feed flow/retentate flow) to achieve a target volume reduction factor (cumulative feed volume/cumulative retentate volume).
In practice, the system uses a control loop to monitor the permeate flow rate and adjust the permeate pump speed accordingly. Initially, when the product concentration is high, a lower target FRF is used. As the product concentration decreases, the target FRF is increased, either in discrete steps or continuously. This allows for efficient concentration of the microfiltration harvest fluid while maintaining a desired final volume.
This approach differs from traditional TFF systems, which often operate at a fixed feed crossflow rate. By actively controlling the permeate flow, ’404 enables the integration of SPTFF with upstream processes like chromatography, where maintaining a consistent flow rate is crucial. This integration minimizes the need for large intermediate holding tanks and streamlines the overall biomanufacturing process, leading to a more efficient and cost-effective production workflow.
In the early 2010s when ’404 was filed, filtration systems were commonly used in biopharmaceutical manufacturing for cell separation, purification, and concentration. At a time when tangential flow filtration (TFF) was typically implemented using multiple passes, single-pass TFF (SPTFF) was emerging as a method to improve efficiency. Systems commonly relied on controlling feed flow and transmembrane pressure to optimize filtration performance. Process control systems were used to monitor and adjust these parameters, but integrating upstream and downstream processes with real-time feedback control was not yet a standard practice.
The examiner allowed the claims because the independent claims 1 and 15 distinguish over the prior art. While the prior art discloses a control system adapted to control feed and permeate pump in response to determination of a flow reduction factor based on the ratio of retentate flow relative to feed flow, it does not suggest the claim language "wherein the flow reduction factor is varied to achieve a target volume reduction factor, where the volume reduction factor is the ratio of cumulative feed volume of the feed flow to cumulative retentate volume of the retentate flow."
This patent contains 23 claims, with claims 1 and 14 being independent. The independent claims are directed to a process control system and a process control method, respectively, both involving a single-pass tangential flow filter and control of a flow reduction factor to achieve a target volume reduction factor. The dependent claims generally elaborate on specific features, variations, or implementations of the system and method described in the independent claims.
Definitions of key terms used in the patent claims.
US Latest litigation cases involving this patent.

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Date
Description
Get instant alerts for new documents